Featuring the nucleosome surface as a therapeutic target

Trends Pharmacol Sci. 2015 May;36(5):263-9. doi: 10.1016/j.tips.2015.02.010. Epub 2015 Mar 30.

Abstract

Chromatin is the major regulator of gene expression and genome maintenance. Proteins that bind the nucleosome, the repetitive unit of chromatin, and the histone H4 tail are critical to establishing chromatin architecture and phenotypic outcomes. Intriguingly, nucleosome-binding proteins (NBPs) and the H4 tail peptide compete for the same binding site at an acidic region on the nucleosome surface. Although the essential facts about the nucleosome were revealed 17 years ago, new insights into its atomic structure and molecular mechanisms are still emerging. Several complex nucleosome:NBP structures were recently revealed, characterizing the NBP-binding sites on the nucleosome surface. Here we discuss the potential of the nucleosome surface as a therapeutic target and the impact and development of exogenous nucleosome-binding molecules (eNBMs).

Keywords: acidic patch; binding protein; chromatin; nucleosome; structure; therapeutic target.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Humans
  • Molecular Docking Simulation
  • Molecular Sequence Data
  • Nucleosomes / chemistry
  • Nucleosomes / drug effects*
  • Nucleosomes / metabolism
  • Peptides / pharmacology
  • Peptidomimetics / pharmacology
  • Protein Binding

Substances

  • Nucleosomes
  • Peptides
  • Peptidomimetics